Complaint

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Ventyx Biosciences, Inc. with Losses to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
Complaint, Suite, Certification, Psoriasis, Ethics, Security (finance)

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.

Key Points: 
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The lead clinical product candidate developed by Ventyx, VTX958, was less effective in the treatment of psoriasis than it portrayed to investors.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in The Children's Place, Inc. with Losses to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
Certification, Ethics, Complaint, Suite, The Children's Place, Security (finance)

Investors who purchased the Company’s securities between March 16, 2023 and February 8, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 29, 2024.

Key Points: 
  • Investors who purchased the Company’s securities between March 16, 2023 and February 8, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 29, 2024.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Nextdoor Holdings, Inc. with Losses to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
Certification, COVID-19, Ethics, Complaint, Suite, Security (finance)

Investors who purchased the Company’s securities between July 6, 2021 and November 8, 2022, inclusive (the “Class Period”), are encouraged to contact the firm before April 29, 2024.

Key Points: 
  • Investors who purchased the Company’s securities between July 6, 2021 and November 8, 2022, inclusive (the “Class Period”), are encouraged to contact the firm before April 29, 2024.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Innodata Inc. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
Certification, Ethics, Research, Goldengate, Complaint, Suite, Silicon, Security (finance)

Investors who purchased the Company’s securities between May 9, 2019 and February 14, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 22, 2024.

Key Points: 
  • Investors who purchased the Company’s securities between May 9, 2019 and February 14, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 22, 2024.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Sunnova Energy International Inc. with Losses to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
NOVA, Certification, Ethics, Complaint, Suite, Security (finance)

Investors who purchased the Company’s securities between February 25, 2020 and December 7, 2023, inclusive (the “Class Period”), are encouraged to contact the firm before April 16, 2024.

Key Points: 
  • Investors who purchased the Company’s securities between February 25, 2020 and December 7, 2023, inclusive (the “Class Period”), are encouraged to contact the firm before April 16, 2024.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

FRIDAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in LuxUrban Hotels Inc. with Losses to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
Certification, Ethics, Complaint, Suite, Royalton Hotel, Security (finance)

Investors who purchased the Company’s securities between November 8, 2023 and February 2, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 12, 2024.

Key Points: 
  • Investors who purchased the Company’s securities between November 8, 2023 and February 2, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before April 12, 2024.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
Radiation, CKPT, Biologics license application, Telephone, District court, Patient, CRL, News, Acquisition, Complaint, P.C, CMO, FDA, BLA, Court, Food, Person, Pharmaceutical industry

Investors have until June 4, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Key Points: 
  • Investors have until June 4, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
  • Checkpoint's lead antibody product candidate is cosibelimab for the treatment of selected recurrent or metastatic cancers.
  • The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies.
  • cites findings that arose during a multi-sponsor inspection of Checkpoint's third-party [CMO] as approvability issues to address in a resubmission."

CC INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Case

Retrieved on: 
Tuesday, April 9, 2024
Annual report, Ethics, CC, SAN, News, Controller, Senior, Complaint, Collection, Audit committee, Tobacco

), the Chemours class action lawsuit charges Chemours as well as certain of Chemours’ top current and former executives with violations of the Securities Exchange Act of 1934.

Key Points: 
  • ), the Chemours class action lawsuit charges Chemours as well as certain of Chemours’ top current and former executives with violations of the Securities Exchange Act of 1934.
  • Lead plaintiff motions for the Chemours class action lawsuit must be filed with the court no later than May 20, 2024.
  • The lead plaintiff can select a law firm of its choice to litigate the Chemours class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Chemours class action lawsuit.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ventyx, and Anavex and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
Psoriasis, Form, Patient, Defendant, News, IPO, Crohn's disease, Security (finance), Inflammation, Rett syndrome, Prospectus, Complaint, P.C, Clinical trial, MCI, Radar, File, Register, Pharmaceutical industry

The Company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.

Key Points: 
  • The Company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.
  • In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • On November 6, 2023, during after-market hours, Ventyx issued a press release announcing results from the Phase 2 SERENITY Trial.
  • For more information on the Anavex class action go to: https://bespc.com/cases/AVXL

LUNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Luna Innovations Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

Retrieved on: 
Tuesday, April 9, 2024
8-K, Committee, Form, News, Luna Innovations, LUNA, Bank statement, Complaint, Retirement, Court, Person, Cryptocurrency

NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Luna Innovations Incorporated (“Luna Innovations” or “the Company”) (NASDAQ: LUNA) and certain of its officers.

Key Points: 
  • NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Luna Innovations Incorporated (“Luna Innovations” or “the Company”) (NASDAQ: LUNA) and certain of its officers.
  • According to the Complaint, Luna Innovations is a technology company that is focused on fiber optics.
  • If you suffered a loss in Luna Innovations you have until May 31, 2024, to request that the Court appoint you as lead plaintiff.
  • Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits.